Invenomic Fund Investor Class shares BIVRX

Morningstar Medalist Rating
  • NAV / 1-Day Return $19.58  /  +4.76 %
  • Fund Size $849.9M
  • Adjusted Expense Ratio 2.490%
  • Net Expense Ratio 3.290%
  • Fee Level: Distribution High
  • Share Class Type No Load
  • Morningstar Category Long-Short Equity
  • Equity Style Box (Funds) Small Value
  • Minimum Initial Investment $5,000
  • Investment Status Limited
  • TTM Yield 1.71%
  • Turnover Ratio 197%

Morningstar’s Analysis BIVRX

Will BIVRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Invenomic Investor holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BIVRX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 28.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us Dollar Broker

69.77 608M
Cash and Equivalents

First American Government Obligs X

8.65 75M
Cash and Equivalents

Workday Inc Class A

3.32 29M
Technology

Salesforce Inc

3.05 27M
Technology

Universal Health Services Inc Class B

3.03 26M
Healthcare

Global Payments Inc

3.01 26M
Industrials

Intuit Inc

2.87 25M
Technology

Fidelity National Information Services Inc

2.81 25M
Technology

Charter Communications Inc Class A

2.75 24M
Communication Services

Australian Dollar

2.59 23M
Cash and Equivalents

Sponsor Center